BioDelivery Sciences International Inc (BDSI) - Financial and Strategic SWOT Analysis Review

BioDelivery Sciences International Inc (BDSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BioDelivery Sciences International Inc (BDSI) is a specialty pharmaceutical company that develops and commercializes products in the areas of addiction medicine and pain management. The companys marketed products include fentanyl buccal soluble solution for breakthrough cancer pain; buprenorphine/naloxone buccal film for opioid dependence; and buprenorphine buccal film for chronic pain. Its pipeline encompasses indications targeted at the treatment of chronic pain and opioid dependence. BDSI employs its proprietary BioErodible MucoAdhesive (BEMA) technology which comprises small, bioerodible polymer film used to facilitate rapid delivery a drug across the mucous membranes for time sensitive conditions. BDSI is headquartered in Raleigh, North Carolina, the US.

BioDelivery Sciences International Inc Key Recent Developments

May 28,2019: BioDelivery Sciences strengthens financial position with debt refinancing
May 06,2019: BioDelivery Sciences reports strong first quarter 2019 results and raises BELBUCA full-year expectations
Mar 14,2019: BioDelivery Sciences reports strong 2018 results and 2019 expectations
Jan 15,2019: BioDelivery Sciences International names Terry Coelho as chief financial officer
Aug 09,2018: BioDelivery Sciences reports strong second quarter 2018 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company




Section 1 - About the Company
BioDelivery Sciences International Inc - Key Facts
BioDelivery Sciences International Inc - Key Employees
BioDelivery Sciences International Inc - Key Employee Biographies
BioDelivery Sciences International Inc - Major Products and Services
BioDelivery Sciences International Inc - History
BioDelivery Sciences International Inc - Company Statement
BioDelivery Sciences International Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
BioDelivery Sciences International Inc - Business Description
Product Category: Belbuca
Overview
Performance
Product Category: Bunavail
Overview
Performance
Product Category: Onsolis
Overview
Performance
Product Category: Contract Revenue
Performance
Product Category: Product Royalty Revenue
Performance
Product Category: Product Sales
Performance
Product Category: Research and Development Reimbursements
Performance
R&D Overview
BioDelivery Sciences International Inc - Corporate Strategy
BioDelivery Sciences International Inc - SWOT Analysis
SWOT Analysis - Overview
BioDelivery Sciences International Inc - Strengths
BioDelivery Sciences International Inc - Weaknesses
BioDelivery Sciences International Inc - Opportunities
BioDelivery Sciences International Inc - Threats
BioDelivery Sciences International Inc - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences Financial Deals and Alliances
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
BioDelivery Sciences International Inc, Recent Deals Summary
Section 5 Companys Recent Developments
May 28, 2019: BioDelivery Sciences strengthens financial position with debt refinancing
May 06, 2019: BioDelivery Sciences reports strong first quarter 2019 results and raises BELBUCA full-year expectations
Mar 14, 2019: BioDelivery Sciences reports strong 2018 results and 2019 expectations
Jan 15, 2019: BioDelivery Sciences International names Terry Coelho as chief financial officer
Aug 09, 2018: BioDelivery Sciences reports strong second quarter 2018 financial results
Jul 30, 2018: BioDelivery Sciences appoints Thomas Smith, MD as chief medical officer further expanding companys expertise in field of pain management
May 10, 2018: BioDelivery Sciences Reports Positive First Quarter 2018 Financial Results and Provides Corporate Update
May 07, 2018: BioDelivery Sciences Names Herm Cukier As Chief Executive Officer
Mar 16, 2018: BioDelivery Sciences Announces Fourth Quarter and Full-Year 2017 Financial Results
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables


BioDelivery Sciences International Inc, Key Facts
BioDelivery Sciences International Inc, Key Employees
BioDelivery Sciences International Inc, Key Employee Biographies
BioDelivery Sciences International Inc, Major Products and Services
BioDelivery Sciences International Inc, History
BioDelivery Sciences International Inc, Subsidiaries
BioDelivery Sciences International Inc, Key Competitors
BioDelivery Sciences International Inc, Ratios based on current share price
BioDelivery Sciences International Inc, Annual Ratios
BioDelivery Sciences International Inc, Annual Ratios (Cont...1)
BioDelivery Sciences International Inc, Interim Ratios
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
BioDelivery Sciences International Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures


BioDelivery Sciences International Inc, Performance Chart (2014 - 2018)
BioDelivery Sciences International Inc, Ratio Charts
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

BioDelivery Sciences International Inc (BDSI) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

BioDelivery Sciences International Inc (BDSI) is a specialty pharmaceutical company which develops and commercializes products in the areas of addiction medicine and pain management. The companys marketed products include fentanyl

USD 250 View Report

BioDelivery Sciences International Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

BioDelivery Sciences International Inc Company Profile is a detailed strategic and analytical report on BioDelivery Sciences International Inc. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

BioDelivery Sciences International Inc (BDSI) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

BioDelivery Sciences International Inc (BDSI) is a specialty pharmaceutical company which develops and commercializes products in the areas of addiction medicine and pain management. The companys marketed products include fentanyl

USD 250 View Report

BioDelivery Sciences International Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

BioDelivery Sciences International Inc Company Profile is a detailed strategic and analytical report on BioDelivery Sciences International Inc. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available